Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors.

The availability of a high-resolution structure of rhodopsin now allows us to reconsider research attempts to understand structure-function relationships in other G protein-coupled receptors (GPCRs). A comparison of the rhodopsin structure with the results of previous sequence analysis and molecular modeling that incorporated experimental results demonstrates a high degree of success for these methods in predicting the helix ends and protein-protein interface of GPCRs. Moreover, the amino acid residues inferred to form the surface of the binding-site crevice based on our application of the substituted-cysteine accessibility method in the dopamine D(2) receptor are in remarkable agreement with the rhodopsin structure, with the notable exception of some residues in the fourth transmembrane segment. Based on our analysis of the data reviewed, we propose that the overall structures of rhodopsin and of amine receptors are very similar, although we also identified localized regions where the structure of these receptors may diverge. We further propose that several of the highly unusual structural features of rhodopsin are also present in amine GPCRs, despite the absence of amino acids that might have thought to have been critical to the adoption of these features. Thus, different amino acids or alternate microdomains can support similar deviations from regular alpha-helical structure, thereby resulting in similar tertiary structure. Such structural mimicry is a mechanism by which a common ancestor could diverge sufficiently to develop the selectivity necessary to interact with diverse signals, while still maintaining a similar overall fold. Through this process, the core function of signaling activation through a conformational change in the transmembrane segments that alters the conformation of the cytoplasmic surface and subsequent interaction with G proteins is presumably shared by the entire Class A family of receptors, despite their selectivity for a diverse group of ligands.

[1]  P. Kitabgi,et al.  Mutagenesis and Modeling of the Neurotensin Receptor NTR1 , 1998, The Journal of Biological Chemistry.

[2]  H. Khorana,et al.  Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. , 1995, Biochemistry.

[3]  D. Oprian,et al.  The ligand-binding domain of rhodopsin and other G protein-linked receptors , 1992, Journal of bioenergetics and biomembranes.

[4]  H. Akil,et al.  Hydrophobic Residues of the D2 Dopamine Receptor Are Important for Binding and Signal Transduction , 1995, Journal of neurochemistry.

[5]  T. Schwartz,et al.  Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor , 1995, Nature.

[6]  D. Oprian,et al.  Tertiary interactions between transmembrane segments 3 and 5 near the cytoplasmic side of rhodopsin. , 1999, Biochemistry.

[7]  F Guarnieri,et al.  Agonist-induced Conformational Changes at the Cytoplasmic Side of Transmembrane Segment 6 in the β2 Adrenergic Receptor Mapped by Site-selective Fluorescent Labeling* , 2001, The Journal of Biological Chemistry.

[8]  O. Lichtarge,et al.  Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.

[9]  T. Branchek,et al.  Modeling and mutagenesis of the human alpha 1a-adrenoceptor: orientation and function of transmembrane helix V sidechains. , 1996, Receptors & channels.

[10]  C Altenbach,et al.  Structural features and light-dependent changes in the sequence 306-322 extending from helix VII to the palmitoylation sites in rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.

[11]  Harel Weinstein,et al.  Three-dimensional representations of G protein-coupled receptor structures and mechanisms. , 2002, Methods in enzymology.

[12]  B. Honig,et al.  An integrated approach to the analysis and modeling of protein sequences and structures. III. A comparative study of sequence conservation in protein structural families using multiple structural alignments. , 2000, Journal of molecular biology.

[13]  A. Smolyar,et al.  Static and dynamic roles of extracellular loops in G-protein-coupled receptors: a mechanism for sequential binding of thyrotropin-releasing hormone to its receptor. , 1998, Biophysical journal.

[14]  M. Caron,et al.  Localization of the fourth membrane spanning domain as a ligand binding site in the human platelet alpha 2-adrenergic receptor. , 1989, Biochemistry.

[15]  S. Rivkees,et al.  Identification of the Adenine Binding Site of the Human A1 Adenosine Receptor* , 1999, The Journal of Biological Chemistry.

[16]  J. Thornton,et al.  Helix geometry in proteins. , 1988, Journal of molecular biology.

[17]  C. Strader,et al.  Allele-specific activation of genetically engineered receptors. , 1991, The Journal of biological chemistry.

[18]  H Weinstein,et al.  Related Contribution of Specific Helix 2 and 7 Residues to Conformational Activation of the Serotonin 5-HT2A Receptor (*) , 1995, The Journal of Biological Chemistry.

[19]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[20]  J. Ballesteros,et al.  Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.

[21]  M. Struthers,et al.  G protein-coupled receptor activation: analysis of a highly constrained, "straitjacketed" rhodopsin. , 2000, Biochemistry.

[22]  J. Baldwin,et al.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.

[23]  R. Graham,et al.  Phe310 in Transmembrane VI of the α1B-Adrenergic Receptor Is a Key Switch Residue Involved in Activation and Catecholamine Ring Aromatic Bonding* , 1999, The Journal of Biological Chemistry.

[24]  A. Egloff,et al.  Replacement of lysine‐181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling , 1992, Journal of cellular biochemistry.

[25]  C. Fraser,et al.  Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. , 1991, Molecular pharmacology.

[26]  B. Roth,et al.  Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5. , 2000, Molecular pharmacology.

[27]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[28]  K. Jacobson,et al.  Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. , 1992, The Journal of biological chemistry.

[29]  J. Ballesteros,et al.  Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment. , 1999, Biochemistry.

[30]  O. Lichtarge,et al.  Similar Structures and Shared Switch Mechanisms of the β2-Adrenoceptor and the Parathyroid Hormone Receptor , 1999, The Journal of Biological Chemistry.

[31]  T. Schwartz,et al.  Connectivity and orientation of the seven helical bundle in the tachykinin NK‐1 receptor probed by zinc site engineering. , 1996, The EMBO journal.

[32]  Yi-Jun Guo,et al.  Molecular basis for the interaction of histamine with the histamine H2 receptor. , 1992, The Journal of biological chemistry.

[33]  Irving S. Sigal,et al.  Structure-Function Analysis of the β-Adrenergic Receptor , 1988 .

[34]  G. Liapakis,et al.  Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors. , 2002, Methods in enzymology.

[35]  G. Crouse Mutagenesis assays in yeast. , 2000, Methods.

[36]  D. Larhammar,et al.  Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT(1B) receptor. , 1999, European journal of pharmacology.

[37]  M. Struthers,et al.  Tertiary interactions between the fifth and sixth transmembrane segments of rhodopsin. , 1999, Biochemistry.

[38]  [8] Domain approach to three-dimensional structure of rhodopsin using high-resolution nuclear magnetic resonance , 2000 .

[39]  Shoshana J. Wodak,et al.  The TXP Motif in the Second Transmembrane Helix of CCR5 , 2001, The Journal of Biological Chemistry.

[40]  L. Naylor,et al.  Structural Studies on D2 Dopamine Receptors: Mutation of a Histidine Residue Specifically Affects the Binding of a Subgroup of Substituted Benzamide Drugs , 1994, Journal of neurochemistry.

[41]  C. Broger,et al.  Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors. , 1995, European journal of biochemistry.

[42]  T. Mavromoustakos,et al.  Amphipathic interactions of cannabinoids with membranes. A comparison between delta 8-THC and its O-methyl analog using differential scanning calorimetry, X-ray diffraction and solid state 2H-NMR. , 1992, Biochimica et biophysica acta.

[43]  B. Kobilka,et al.  Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors. , 1992, Molecular pharmacology.

[44]  S. W. Lin,et al.  Analysis of functional microdomains of rhodopsin. , 2000, Methods in enzymology.

[45]  Manju Bansal,et al.  Geometrical and Sequence Characteristics of α-Helices in Globular Proteins , 1998 .

[46]  U. Gether Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.

[47]  J. Ballesteros,et al.  A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. , 1998, Biochemistry.

[48]  D. Perez,et al.  Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding. , 1996, Molecular pharmacology.

[49]  B. Roth,et al.  Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors. , 1997, Molecular pharmacology.

[50]  S. Vishveshwara,et al.  Geometry of proline-containing alpha-helices in proteins. , 2009, International journal of peptide and protein research.

[51]  C. Strader,et al.  Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation. , 2000, Molecular pharmacology.

[52]  B. Roth,et al.  A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors. , 1993, Molecular pharmacology.

[53]  B. Matthews,et al.  Intrahelical hydrogen bonding of serine, threonine and cysteine residues within alpha-helices and its relevance to membrane-bound proteins. , 1984, Journal of molecular biology.

[54]  J. Wess,et al.  Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition. , 1996, Molecular pharmacology.

[55]  Gebhard F. X. Schertler,et al.  Arrangement of rhodopsin transmembrane α-helices , 1997, Nature.

[56]  J. Ballesteros,et al.  Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice. , 1996, Biochemistry.

[57]  T. Schwartz,et al.  Is there a 'lock' for all agonist 'keys' in 7TM receptors? , 1996, Trends in pharmacological sciences.

[58]  C. Strader,et al.  Identification and sequence of a binding site peptide of the beta 2-adrenergic receptor. , 1988, Biochemistry.

[59]  In vitro selected oligonucleotides as receptors in binding assays. , 2000, Methods.

[60]  B. Roth,et al.  Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. , 1995, Molecular pharmacology.

[61]  D. Larhammar,et al.  Mutagenesis of the human 5-HT1B receptor: differences from the closely related 5-HT1A receptor and the role of residue F331 in signal transduction. , 1998, Journal of receptor and signal transduction research.

[62]  I. Gantz,et al.  Molecular Basis for the Interaction of [Nle4,d-Phe7]Melanocyte Stimulating Hormone with the Human Melanocortin-1 Receptor (Melanocyte α-MSH Receptor)* , 1997, The Journal of Biological Chemistry.

[63]  H Weinstein,et al.  Mapping the Binding Site Pocket of the Serotonin 5-Hydroxytryptamine2A Receptor , 1996, The Journal of Biological Chemistry.

[64]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2000, Science.

[65]  O. Civelli,et al.  Site-directed mutagenesis of the human dopamine D 2 receptor , 2003 .

[66]  J. Venter,et al.  Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. , 1989, Molecular pharmacology.

[67]  Catherine,et al.  dentific ~ tion f Two Serine Residues Involved in Agonist Activation of the & Adrenergic Receptor ” , 2022 .

[68]  T. Sakmar,et al.  [9] Analysis of functional microdomains of rhodopsin , 2000 .

[69]  Mark S.P. Sansom,et al.  Hinges, swivels and switches: the role of prolines in signalling via transmembrane α-helices , 2000 .

[70]  L. Pardo,et al.  Serine and Threonine Residues Bend a-Helices in the x 1 5 g 2 Conformation , 2000 .

[71]  L. Mirny,et al.  Universally conserved positions in protein folds: reading evolutionary signals about stability, folding kinetics and function. , 1999, Journal of molecular biology.

[72]  G J Barton,et al.  Structural features can be unconserved in proteins with similar folds. An analysis of side-chain to side-chain contacts secondary structure and accessibility. , 1994, Journal of molecular biology.

[73]  D. Larhammar,et al.  Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT1B receptor , 1999 .

[74]  Elaine C. Meng,et al.  An Activation Switch in the Ligand Binding Pocket of the C5a Receptor* , 2001, The Journal of Biological Chemistry.

[75]  M Krook,et al.  Short-chain dehydrogenases/reductases (SDR). , 1995, Biochemistry.

[76]  A. Karlin,et al.  Substituted-cysteine accessibility method. , 1998, Methods in enzymology.

[77]  T. Sakmar,et al.  Functional Interaction of Transmembrane Helices 3 and 6 in Rhodopsin , 1996, The Journal of Biological Chemistry.

[78]  H. Akil,et al.  Site-directed mutagenesis of the human dopamine D2 receptor. , 1992, European journal of pharmacology.

[79]  H Weinstein,et al.  The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. , 2000, Biochemistry.

[80]  D. Oprian,et al.  STATE-DEPENDENT DISULFIDE CROSS-LINKING IN RHODOPSIN , 1999 .

[81]  D. Pappin,et al.  The structure of mammalian rod opsins , 1984, Vision Research.

[82]  S. White,et al.  Membrane protein folding and stability: physical principles. , 1999, Annual review of biophysics and biomolecular structure.

[83]  C. Reynolds,et al.  A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors. , 1997, Journal of medicinal chemistry.

[84]  J. Ballesteros,et al.  Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains. , 1992, Biophysical journal.

[85]  C. Strader,et al.  Structure-function analysis of the beta-adrenergic receptor. , 1988, Cold Spring Harbor symposia on quantitative biology.

[86]  J. Javitch,et al.  A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[87]  H. Nelson,et al.  Role of an alpha-helical bulge in the yeast heat shock transcription factor. , 2000, Journal of molecular biology.

[88]  Leonardo Pardo,et al.  Serine and Threonine Residues Bend α-Helices in the χ1 = g− Conformation , 2000 .

[89]  J. Ballesteros,et al.  The Forgotten Serine , 2000, The Journal of Biological Chemistry.

[90]  T. Schwartz,et al.  Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[91]  E. Hulme,et al.  A Network of Conserved Intramolecular Contacts Defines the Off-state of the Transmembrane Switch Mechanism in a Seven-transmembrane Receptor* , 2000, The Journal of Biological Chemistry.

[92]  C. Strader,et al.  Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. , 1988, The Journal of biological chemistry.

[93]  J. Wess,et al.  Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A2a Adenosine Receptor (*) , 1995, The Journal of Biological Chemistry.

[94]  J. Wess,et al.  Site‐directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. , 1991, The EMBO journal.

[95]  J. Ballesteros,et al.  The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. , 2000, Biochemistry.

[96]  D. Donnelly,et al.  The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor. , 1996, The Journal of Biological Chemistry.

[97]  T. Sakmar,et al.  Rhodopsin: structural basis of molecular physiology. , 2001, Physiological reviews.

[98]  T. Schwartz,et al.  Metal‐Ion Sites as Structural and Functional Probes of Helix–Helix Interactions in 7TM Receptors , 1997, Annals of the New York Academy of Sciences.

[99]  C. Strader,et al.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.

[100]  B. Kobilka,et al.  A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists. , 1991, The Journal of biological chemistry.

[101]  S. Moro,et al.  Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. , 1998, Journal of medicinal chemistry.

[102]  B. Kobilka,et al.  Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity. , 1993, Molecular pharmacology.

[103]  K. Jacobson,et al.  A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor. , 1997, Molecular pharmacology.

[104]  D. Oprian,et al.  Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness , 1994, Nature.

[105]  J. Wess,et al.  Mutational Analysis of the Relative Orientation of Transmembrane Helices I and VII in G Protein-coupled Receptors (*) , 1995, The Journal of Biological Chemistry.

[106]  J. Ballesteros,et al.  Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. , 1999, Molecular pharmacology.

[107]  K Konvicka,et al.  A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. , 1994, Molecular pharmacology.

[108]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[109]  B Honig,et al.  An integrated approach to the analysis and modeling of protein sequences and structures. II. On the relationship between sequence and structural similarity for proteins that are not obviously related in sequence. , 2000, Journal of molecular biology.

[110]  R. Schwyzer 100 Years lock‐and‐key concept: Are peptide keys shaped and guided to their receptors by the target cell membrane? , 1995, Biopolymers.

[111]  J. Javitch,et al.  Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice. , 1995, Biochemistry.

[112]  B. Lee,et al.  The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.

[113]  T. Sakmar,et al.  Spectroscopic evidence for interaction between transmembrane helices 3 and 5 in rhodopsin. , 1998, Biochemistry.

[114]  N. J. Gibson,et al.  Lipid headgroup and acyl chain composition modulate the MI-MII equilibrium of rhodopsin in recombinant membranes. , 1993, Biochemistry.

[115]  Jonathan A Javitch,et al.  Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method , 1995, Neuron.

[116]  J. Demartino,et al.  The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. , 1994, The Journal of biological chemistry.

[117]  M. Gerstein,et al.  Assessing annotation transfer for genomics: quantifying the relations between protein sequence, structure and function through traditional and probabilistic scores. , 2000, Journal of molecular biology.

[118]  J. Shafer,et al.  Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate. , 1986, Biochemistry.

[119]  D. Faury,et al.  Demonstration by transfection studies that mutations in the adrenocorticotropin receptor gene are one cause of the hereditary syndrome of glucocorticoid deficiency. , 1996, The Journal of clinical endocrinology and metabolism.

[120]  T. Ikegami,et al.  Conformation of a peptide ligand bound to its G-protein coupled receptor , 2001, Nature Structural Biology.

[121]  H. Khorana,et al.  Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.

[122]  J. T. Turner,et al.  Site-directed Mutagenesis of P2U Purinoceptors , 1995, The Journal of Biological Chemistry.

[123]  H. Khorana,et al.  Structure and function in rhodopsin. Cysteines 65 and 316 are in proximity in a rhodopsin mutant as indicated by disulfide formation and interactions between attached spin labels. , 1996, Biochemistry.

[124]  J. Wess,et al.  Use of a Disulfide Cross-linking Strategy to Study Muscarinic Receptor Structure and Mechanisms of Activation* , 1999, The Journal of Biological Chemistry.

[125]  H. Feirabend,et al.  Preservation and staining of myelinated nerve fibers. , 1998, Methods.

[126]  A. Karlin,et al.  Acetylcholine receptor channel structure probed in cysteine-substitution mutants. , 1992, Science.

[127]  W. Greenlee,et al.  Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: susceptibility to receptor mutations. , 1997, Molecular pharmacology.

[128]  S. Lazareno,et al.  Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. , 1995, Molecular pharmacology.

[129]  C. Strader,et al.  Identification of residues required for ligand binding to the beta-adrenergic receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[130]  L. F. Kolakowski,et al.  The Role of the Cholecystokinin-B/Gastrin Receptor Transmembrane Domains in Determining Affinity for Subtype-selective Ligands(*) , 1995, The Journal of Biological Chemistry.

[131]  A. Tucker,et al.  A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition. , 1994, The Journal of biological chemistry.

[132]  A. IJzerman,et al.  Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[133]  J. Klein-Seetharaman,et al.  Structural features and light-dependent changes in the sequence 59-75 connecting helices I and II in rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.

[134]  C. Fraser,et al.  Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. , 1992, The Journal of biological chemistry.

[135]  A. Shrake,et al.  Environment and exposure to solvent of protein atoms. Lysozyme and insulin. , 1973, Journal of molecular biology.

[136]  Takao Shimizu,et al.  Alanine Exchanges of Polar Amino Acids in the Transmembrane Domains of a Platelet-activating Factor Receptor Generate Both Constitutively Active and Inactive Mutants* , 1997, The Journal of Biological Chemistry.

[137]  M. Maze,et al.  Arrangement of Transmembrane Domains in Adrenergic Receptors , 1996, The Journal of Biological Chemistry.

[138]  B. O'dowd,et al.  A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors , 1992, Nature.